stella
beta
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization — Stella
Recruiting
Back to Inflammatory Bowel Diseases trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(15 sites)
Belgium
AZ Maria Middelares, Ghent, Oost-Vlaanderen
AZ Oostende, Ostend, West-Vlaanderen
Universitair ziekenhuis Antwerpen, Antwerp
Imeldaziekenhuis, Bonheiden
AZ Sint-Jan Brugge, Bruges
Show all 15 locations
View full record on ClinicalTrials.gov